NasdaqCM - Nasdaq Real Time Price • USD
UFP Technologies, Inc. (UFPT)
As of 3:00 PM EDT. Market Open.
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 3 | 3 | 3 | 3 |
| Avg. Estimate | 1.1 | 1.35 | 5.93 | 6.77 |
| Low Estimate | 1.05 | 1.26 | 5.26 | 5.83 |
| High Estimate | 1.17 | 1.5 | 6.28 | 7.25 |
| Year Ago EPS | 1.27 | 1.55 | 5.83 | 5.93 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 3 | 3 | 3 | 3 |
| Avg. Estimate | 97.3M | 105.23M | 431.67M | 468.5M |
| Low Estimate | 95.4M | 101.1M | 423.8M | 454.7M |
| High Estimate | 98.3M | 109.2M | 440.1M | 483.9M |
| Year Ago Sales | 97.75M | -- | 400.07M | 431.67M |
| Sales Growth (year/est) | -0.50% | -- | 7.90% | 8.50% |
Earnings History
| CURRENCY IN USD | 3/31/2023 | 6/30/2023 | 9/30/2023 | 12/31/2023 |
|---|---|---|---|---|
| EPS Est. | 1.04 | 1.42 | 1.52 | 1.13 |
| EPS Actual | 1.27 | 1.55 | 1.52 | 1.51 |
| Difference | 0.23 | 0.13 | 0 | 0.38 |
| Surprise % | 22.10% | 9.20% | 0.00% | 33.60% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 1.1 | 1.35 | 5.93 | 6.77 |
| 7 Days Ago | 1.1 | 1.35 | 5.93 | 6.77 |
| 30 Days Ago | 1.06 | 1.27 | 5.77 | 6.52 |
| 60 Days Ago | 1.26 | 1.52 | 6.01 | 6.24 |
| 90 Days Ago | 1.26 | 1.52 | 6.28 | 0 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| CURRENCY IN USD | UFPT | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | -13.40% | -- | -- | 0.80% |
| Next Qtr. | -12.90% | -- | -- | 9.60% |
| Current Year | 1.70% | -- | -- | 4.50% |
| Next Year | 14.20% | -- | -- | 13.30% |
| Next 5 Years (per annum) | -- | -- | -- | 11.09% |
| Past 5 Years (per annum) | 27.43% | -- | -- | -- |
Research Analysis
Analyst Price Targets
Fair Value
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Analyst Recommendations
- Strong Buy
- Buy
- Hold
- Underperform
- Sell
Earnings
Upgrades & Downgrades
| Initiated | CJS Securities: Market Outperform | 3/20/2024 |
| Initiated | Keybanc: Sector Weight | 2/6/2024 |
| Maintains | Lake Street: Buy to Buy | 6/26/2023 |
| Maintains | Lake Street: Buy | 5/3/2023 |
| Maintains | Lake Street: Buy | 3/8/2023 |
| Initiated | Lake Street: Buy | 6/22/2022 |
Related Tickers
BRKR Bruker Corporation
77.31
-1.60%
BVS Bioventus Inc.
4.4850
-1.43%
RXST RxSight, Inc.
50.83
-1.78%
ITGR Integer Holdings Corporation
116.29
-1.31%
ELMD Electromed, Inc.
14.47
+3.80%
IRMD IRADIMED CORPORATION
41.13
+1.90%
KIDS OrthoPediatrics Corp.
30.00
+1.83%
TLSI TriSalus Life Sciences, Inc.
9.86
+0.31%
STE STERIS plc
198.93
-0.94%
TELA TELA Bio, Inc.
4.7200
-8.37%